Cancer Research Institute
CRI Clinical Innovator
Protocol Concept Deadline
Last seen in a scan/import: .
Catalog updated: .
These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.
The CRI Clinical Innovator Grant funds pioneering immunotherapy clinical trials designed and led by academic researchers, with awards up to $1 million. This programme targets clinician-scientists and physician-researchers who are principal investigators on therapeutic immunology trials. The call runs annually with a two-stage process: protocol concepts compete in the first round, with selected teams advancing to full proposals.
Details
| Funder | Cancer Research Institute |
| Budget | $1M |
| Deadline | 1 December 2026 |
| Consortium | No |
| Application | 2-stage: Protocol Concept → full application |
| Frequency | Annual |
Eligibility & scope
Supports pioneering immunotherapy clinical trials designed and led by academic researchers. Requires a clinical trial focus; applicants must be academic investigators leading immunotherapy trials.
Who Should Apply
- •Academic researchers leading immunotherapy clinical trials as principal investigator
- •Clinician-scientists and physician-researchers with trial oversight authority
- •Trials testing novel immunotherapy approaches in cancer patients
- •Researchers at academic medical centers and research institutions
Key Dates
- •Protocol Concept Deadline: 1 December 2026
- •Two-stage evaluation: protocol concept submission followed by full proposal for selected teams
- •Annual call cycle
Tips for Applicants
- ✓Lead with trial novelty and unmet clinical need, CRI panels prioritize immunotherapy approaches with clear therapeutic potential over incremental modifications.
- ✓Protocol concepts are scored partly on feasibility and team expertise; name your clinical collaborators and biostatistician early to strengthen implementation credibility.
- ✓The full proposal stage is decisive; use the feedback from concept review to sharpen your trial design and anticipated immune endpoints.
Frequently Asked Questions
How much does the CRI Clinical Innovator Grant provide?
Awards up to $1 million to support pioneering immunotherapy clinical trials.
Who can apply for the CRI Clinical Innovator Grant?
Academic researchers who are principal investigators on immunotherapy clinical trials, typically clinician-scientists and physician-researchers.
What is the deadline for the CRI Clinical Innovator Grant?
The Protocol Concept Deadline is 1 December 2026; selected teams then submit full proposals in a second stage.
Is the CRI Clinical Innovator Grant open to any disease area?
The grant focuses specifically on immunotherapy trials, with a cancer research focus through the Cancer Research Institute's mission.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Clinical Innovator
Cancer Research InstituteDeadline: 1 Dec 2026$1MCRI Clinic and Laboratory Integration Program
Cancer Research InstituteDeadline: 1 Dec 2026$300,000Technology Impact Award
Cancer Research InstituteDeadline: 15 Nov 2026Up to $600,000 over 2-4 years, plus up to 10% indirect costsCRI Technology Impact Award
Cancer Research InstituteDeadline: 16 Nov 2026$600,000Ignite Award
Cancer Research InstituteDeadline: 1 Feb 2027Up to $1.05M across two conditional phases
Browse Related
Could CRI Clinical Innovator be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →